Hematology Webinars

The goals of these webinars are to help participants increase their knowledge of current tools and technologies available for patient sample analysis, better understand the accepted methodologies and benchmarks for patient sample analysis and diagnosis, and to increase their competence in using analytical software applications.

Hematology
0
Urinalysis
0
Flow Cytometry
0

MDS: What You Need to Know About Cytopenia, Dysplasia & Mutations

This session will explore novel aspects of laboratory hematology that advance the diagnostic work-up of myeloid malignancies. A series of clinical case studies will be presented that highlight laboratory testing beyond the routine CBC. The examples and discussion will provide an overview of myeloid malignancy work-ups.

Unusual Cases: Bridging Hematology With Flow Cytometry

Multiparameter flow cytometry has become an integral tool in the work-up of abnormal WBC findings, allowing for rapid and accurate identification of abnormal cell populations, cell lineage assignment and assessment of clonality. This presentation will discuss a series of cases that demonstrate the utility of flow cytometry in the diagnostic workup of hematologic disorders presenting with abnormal WBC differential and incorporation of relevant criteria from the revised WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Clinical Utility of Immature Platelet Fraction

Advances in hematology testing offer parameters useful in assessing challenging conditions such as thrombocytopenia. This presentation provides an overview of immature platelet parameters (IPF% and IPF#) and discusses their clinical utility. Case studies will be presented to highlight the value of these parameters in assessing bone marrow activity and effective thrombopoiesis.

A Little Look at Lymphoid But Mostly Myeloma

This presentation takes an in depth look at the function of lymphoid cells, describes their role in immunologic response, and outlines the impact to normal and abnormal processes. In addition, plasma cells and plasma cell myeloma will be reviewed using case studies to highlight ensuing patient conditions and associated findings.

Who Knew There Was So Much to Know about Retics?

Advances in the understanding of reticulocyte biology have been associated with advances in instrument technology.

Platelets Purpose, Pictures plus Problems

From the very basic stem cell, pluripotent stem cell as it progresses to the progenitor cell, it is designed to work in the myeloid section.

Fight the Flight Simplifying Body Fluid Analysis

Manual and automated counting techniques, to recognize normal cells found in body fluids and to recognize characteristics of malignant cells.

Evaluation of Neonatal Anemia and Thrombocytopenia

This session will review the incidence, clinical significance, and diagnostic evaluation of anemia, iron deficiency and thrombocytopenia in neonates.

Effective Adoption of Advanced Clinical Parameters

This presentation will explore how one institution was able to make effective use of the Advanced Hematology Parameters that include Immature Granulocytes (IG), Reticulocyte Hemoglobin (RET-He), and Immature Platelet Fraction (IPF).

Evaluation of leukocytosis

This presentation reviews newer hematology analyzers that analyze thousands of leukocytes using flow cytometric based methodology, some in combination with cytochemistry or fluorescence or conductivity to elucidate different types of white cells, NRBCs, and in some cases immature granulocytes

Extended laboratory testing in the evaluation for hematologic neoplasia

Discussing testing that occurs downstream of the CBC report when a diagnosis of hematologic neoplasia such as leukemia, lymphoma, and myelodysplasia is suspected.

Future of quality control

The presentation discusses the Future of Quality Control: Evidence Based QC

Use of reticulocyte hemoglobin in anemia assessment

The presentation objectives for this webinar will include: identifying strategies to better assist clinicians in understanding wellness, prevention and chronic disease management by using Reticulocycte Hemoglobin or RET-He.